InterventionsHuman trial

Semaglutide Improves Tissue-Specific Insulin Action and Reduces Liver Fat in Type 2 Diabetes with Spinal Cord Injury

ADA Scientific Sessions 2026 Abstract

The paper

ALAMDARI A, TRBOVICH ME, HOEKSTRA S et al.

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Late-breaking 2821-LB

doi.org/10.2337/db26-2821-lb

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Diabetes and low muscle mass concentrate vertebral fractures
Frontiers in Public Health · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026